Unveiling the future: Advancements in MRI imaging for neurodegenerative disorders
- PMID: 38364912
- DOI: 10.1016/j.arr.2024.102230
Unveiling the future: Advancements in MRI imaging for neurodegenerative disorders
Abstract
Neurodegenerative disorders represent a significant and growing global health challenge, necessitating continuous advancements in diagnostic tools for accurate and early detection. This work explores the recent progress in Magnetic Resonance Imaging (MRI) techniques and their application in the realm of neurodegenerative disorders. The introductory section provides a comprehensive overview of the study's background, significance, and objectives. Recognizing the current challenges associated with conventional MRI, the manuscript delves into advanced imaging techniques such as high-resolution structural imaging (HR-MRI), functional MRI (fMRI), diffusion tensor imaging (DTI), and positron emission tomography-MRI (PET-MRI) fusion. Each technique is critically examined regarding its potential to address theranostic limitations and contribute to a more nuanced understanding of the underlying pathology. A substantial portion of the work is dedicated to exploring the applications of advanced MRI in specific neurodegenerative disorders, including Parkinson's disease, Alzheimer's disease, Huntington's disease, and Amyotrophic Lateral Sclerosis (ALS). In addressing the future landscape, the manuscript examines technological advances, including the integration of machine learning and artificial intelligence in neuroimaging. The conclusion summarizes key findings, outlines implications for future research, and underscores the importance of these advancements in reshaping our understanding and approach to neurodegenerative disorders.
Keywords: Alzheimer's Disease; Brain Tumor; Magnetic Resonance Imaging; Molecular Imaging; Neurodegenerative Disorders.
Copyright © 2024 Elsevier B.V. All rights reserved.
Conflict of interest statement
Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Similar articles
-
Diffusion-MRI in neurodegenerative disorders.Magn Reson Imaging. 2015 Sep;33(7):853-76. doi: 10.1016/j.mri.2015.04.006. Epub 2015 Apr 23. Magn Reson Imaging. 2015. PMID: 25917917 Review.
-
MR Biomarkers of Degenerative Brain Disorders Derived From Diffusion Imaging.J Magn Reson Imaging. 2020 Dec;52(6):1620-1636. doi: 10.1002/jmri.27019. Epub 2019 Dec 13. J Magn Reson Imaging. 2020. PMID: 31837086 Free PMC article. Review.
-
Principles of diffusion kurtosis imaging and its role in early diagnosis of neurodegenerative disorders.Brain Res Bull. 2018 May;139:91-98. doi: 10.1016/j.brainresbull.2018.01.015. Epub 2018 Jan 31. Brain Res Bull. 2018. PMID: 29378223 Review.
-
Advanced magnetic resonance imaging of neurodegenerative diseases.Neurol Sci. 2017 Jan;38(1):41-51. doi: 10.1007/s10072-016-2764-x. Epub 2016 Nov 15. Neurol Sci. 2017. PMID: 27848119 Review.
-
Animal models of neurodegenerative disease: insights from in vivo imaging studies.Mol Imaging Biol. 2007 Jul-Aug;9(4):186-95. doi: 10.1007/s11307-007-0093-4. Mol Imaging Biol. 2007. PMID: 17357857 Review.
Cited by
-
Brain Age Prediction Using Multi-Hop Graph Attention Combined with Convolutional Neural Network.Bioengineering (Basel). 2024 Mar 8;11(3):265. doi: 10.3390/bioengineering11030265. Bioengineering (Basel). 2024. PMID: 38534539 Free PMC article.
-
Global research trends in biomarkers, therapeutic targets, and drugs for amyotrophic lateral sclerosis: a bibliometric and visualization analysis.Front Pharmacol. 2025 Apr 7;16:1588968. doi: 10.3389/fphar.2025.1588968. eCollection 2025. Front Pharmacol. 2025. PMID: 40260387 Free PMC article.
-
Exosomes in Regulating miRNAs for Biomarkers of Neurodegenerative Disorders.Mol Neurobiol. 2025 Jun;62(6):7576-7596. doi: 10.1007/s12035-025-04733-8. Epub 2025 Feb 7. Mol Neurobiol. 2025. PMID: 39918711 Review.
-
Advancements in deep learning for early diagnosis of Alzheimer's disease using multimodal neuroimaging: challenges and future directions.Front Neuroinform. 2025 May 2;19:1557177. doi: 10.3389/fninf.2025.1557177. eCollection 2025. Front Neuroinform. 2025. PMID: 40385089 Free PMC article. Review.
-
Longitudinal tract-based spatial statistics analysis of white matter diffusivity changes and cognitive decline during the transition from MCI to Alzheimer's disease.PLoS One. 2025 Aug 5;20(8):e0329893. doi: 10.1371/journal.pone.0329893. eCollection 2025. PLoS One. 2025. PMID: 40763286 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous